Lazard Asset Management LLC Cytosorbents Corp Transaction History
Lazard Asset Management LLC
- $58.2 Billion
- Q1 2025
A detailed history of Lazard Asset Management LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 954 shares of CTSO stock, worth $829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
954Holding current value
$829% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
17.2MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$4.39 Million0.55% of portfolio
-
Skylands Capital, LLC3MShares$2.61 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.7 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.46 Million0.0% of portfolio
-
Cm Management, LLC954KShares$830,0461.04% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37.9M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...